Breaking News, Financial News

Financial Report: Allergan

Specialty pharma sales up 14% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Allergan 3Q Revenues:  $1.8 billion (+17%) 3Q Earnings: $312.5 million (+4%) YTD Revenues: $5.3 billion (+15%) YTD Earnings: $989.7 million (+47%) Comments: Specialty pharmaceutical sales increased 14% to $1.5 billion in the quarter. Eye Care Pharmaceutical sales were $818.8 million in the quarter, up 14%. Botox/Neuromodulators sales were $560.1 million, up 15%. Total core medical device sales increased 30% to $258.9 million. Regarding the unsolicited proposal from Valeant, on September 15 ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters